Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR7 | Q9NYK1 | 20/20 | 0.66 |
| ▸ | TLR8 | Q9NR97 | 7/20 | 0.66 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL147627 | 1.00 | TLR7 (0.66) | TLR7TLR8NUDT1 | |
| SCHEMBL12213294 | 0.91 | TLR7 (0.60) | TLR7TLR8NUDT1 | |
| SCHEMBL10264358 | 0.88 | TLR7 (0.51) | TLR7TLR8NUDT1 | |
| SCHEMBL10264278 | 0.88 | TLR7 (0.51) | TLR7TLR8NUDT1 | |
| SCHEMBL3265607 | 0.87 | TLR7 (0.63) | TLR7TLR8NUDT1 | |
| SCHEMBL10264662 | 0.87 | TLR7 (0.50) | TLR7TLR8NUDT1 | |
| SCHEMBL3179251 | 0.87 | TLR7 (0.49) | TLR7TLR8NUDT1 | |
| SCHEMBL10265062 | 0.85 | TLR7 (0.48) | TLR7TLR8NUDT1 | |
| SCHEMBL13505053 | 0.84 | TLR7 (0.62) | TLR7TLR8NUDT1 | |
| SCHEMBL144931 | 0.83 | TLR7 (0.53) | TLR7TLR8NUDT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4183412-B1 | RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2024-08-14 | — | — | EP | disclosed |
| US-20230348574-A1 | RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2023-11-02 | — | — | US | disclosed |
| US-20230072995-A1 | RSV IMMUNIZATION REGIMEN | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2023-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230348574-A1 | RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME | RNASEL, TIMCC, RNGTT | TLR7 349/4885TLR8 1489/4885NUDT1 1255/4885 |
| US-20230072995-A1 | RSV IMMUNIZATION REGIMEN | IL5, IL15, IFNG | TLR7 48/4885TLR8 77/4885NUDT1 3283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.